Is this C+CsC Lumen the same as the C+CsC composite fusion spinal device that was mentioned in the 11/22/16 press release? If so, notice how long it's taken for the company to get it this point since they mention in that press release that the FDA did not clear their 510(k) premarket application but the company was going to look for a new pathway to bring it back. If so, I agree that we must be very close. If it's not the same thing, I don't remember ever hearing anything else about it.
By the way that 11/22/16 PR introduces Dana Lyons as the new Vice President of Sales and Marketing, listing all of his accolades. It's a very good read. I would encourage people to look at it again and ask yourself why a person like him would leave Zimmer to come to AMDA when his star was rising in the company. Also I found this little excerpt interesting:
Mr. Lyons said: "I am excited to join Amedica at a critical turn-around stage, when the spine market is looking for a new material platform. We can drive the adoption of silicon nitride in the spinal fusion market, where it is the perfect solution for relevant clinical concerns. The unique material attributes of silicon nitride create an ideal choice for spinal fusion surgery."
News 
Market Data 
Discover 
AI
